Rapid Management of Trigeminal Neuralgia and Comorbid Major Depressive Disorder With Duloxetine

Annals of Pharmacotherapy

Volumn 48, Issue 8, 2014, Pages 1090-1092

  Hsu, Chung Chih ^a   Chang, Chun Wei ^a   Peng, Chia Ho ^a   Liang, Chih Sung ^a,b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

depression; desynchronization; duloxetine; NMDA receptor; trigeminal neuralgia

Indexed keywords

BACLOFEN; CARBAMAZEPINE; DICLOFENAC; DULOXETINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NORADRENALIN; PARACETAMOL; SEROTONIN; VALPROIC ACID;

ADULT; ANALGESIC ACTIVITY; ARTICLE; CASE REPORT; CELL ACTIVATION; CLINICAL FEATURE; COMORBIDITY; DRUG DOSE INCREASE; DRUG MECHANISM; FEMALE; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; HUMAN; MAJOR DEPRESSION; NERVE CELL; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; TRIGEMINAL NERVE; TRIGEMINUS NEURALGIA;

EID: 84904509871     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028014532789     Document Type: Article

References (20)

1. Macianskyte D,Januzis G,Kubilius R,Adomaitiene V,Sciupokas A.Associations between chronic pain and depressive symptoms in patients with trigeminal neuralgia.Medicina (Kaunas). 2011;47:386-392.
2. Vranken JH.Mechanisms and treatment of neuropathic pain.Cent Nerv Syst Agents Med Chem. 2009;9:71-78.
3. Cruccu G,Gronseth G,Alksne J,et al.AAN-EFNS guidelines on trigeminal neuralgia management.Eur J Neurol. 2008;15:1013-1028.
4. Lunn MP,Hughes RA,Wiffen PJ.Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia.Cochrane Database Syst Rev. 2014; (1): CD007115.
5. Anand KS,Dhikav V,Prasad A,Shewtengna. Efficacy, safety and tolerability of duloxetine in idiopathic trigeminal neuralgia.J Indian Med Assoc. 2011;109:264-266.
6. Goldstein DJ,Lu Y,Detke MJ,Lee TC,Iyengar S.Duloxetine vs. placebo in patients with painful diabetic neuropathy.Pain. 2005;116:109-118.
7. Kajdasz DK,Iyengar S,Desaiah D,et al.Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies.Clin Ther. 2007;29:2536-2546.
8. Bymaster FP,Lee TC,Knadler MP,Detke MJ,Iyengar S.The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression.Curr Pharm Des. 2005;11:1475-1493.
9. Verdu B,Decosterd I,Buclin T,Stiefel F,Berney A.Antidepressants for the treatment of chronic pain.Drugs. 2008;68:2611-2632.
10. Perahia DG,Pritchett YL,Desaiah D,Raskin J.Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?.Int Clin Psychopharmacol. 2006;21:311-317.
11. Zomkowski AD,Engel D,Cunha MP,Gabilan NH,Rodrigues AL.The role of the NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of duloxetine in the forced swimming test.Pharmacol Biochem Behav. 2012;103:408-417.
12. Calabrese F,Guidotti G,Molteni R,Racagni G,Mancini M,Riva MA.Stress-induced changes of hippocampal NMDA receptors: modulation by duloxetine treatment.PLoS One. 2012;7:e37916.
13. Levy D,Zochodne DW.NO pain: potential roles of nitric oxide in neuropathic pain.Pain Pract. 2004;4:11-18.
14. Wu LJ,Zhuo M.Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain.Neurotherapeutics. 2009;6:693-702.
15. Lussier D,Huskey AG,Portenoy RK.Adjuvant analgesics in cancer pain management.Oncologist. 2004;9:571-591.
16. Levy D,Tal M,Hoke A,Zochodne DW.Transient action of the endothelial constitutive nitric oxide synthase (ecNOS) mediates the development of thermal hypersensitivity following peripheral nerve injury.Eur J Neurosci. 2000;12:2323-2332.
17. Devor M,Amir R,Rappaport ZH.Pathophysiology of trigeminal neuralgia: the ignition hypothesis.Clin J Pain. 2002;18:4-13.
18. Angulo MC,Kozlov AS,Charpak S,Audinat E.Glutamate released from glial cells synchronizes neuronal activity in the hippocampus.J Neurosci. 2004;24:6920-6927.
19. Molina LA,Skelin I,Gruber AJ.Acute NMDA receptor antagonism disrupts synchronization of action potential firing in rat prefrontal cortex.PLoS One. 2014;9:e85842.
20. Attal N,Cruccu G,Baron R,et al.EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision.Eur J Neurol. 2010;17:1113-1123.